Dapivirine HIV Ring: A Gamechanger For African Women
IPM To File Approval Applications This Year
The EU’s backing for a new prophylactic vaginal ring containing dapirivine is being seen as a welcome addition to efforts to tackle the spread of HIV in lower resourced countries, particularly in sub-Saharan Africa. But there are still some hurdles to overcome before it can be made available to those who are in most urgent need.
You may also be interested in...
Takeda will soon seek EU approval of its dengue vaccine candidate. The marketing application will be fast-tracked, as will the applications for Regeneron's evinacumab and bluebird bio's eli-cel Lenti-D gene therapy.
GlaxoSmithKline's first-of-its kind treatment for multiple myeloma is among 11 new medicines that have won an EU approval nod from the European Medicines Agency this week.
As the World Health Organization brands the Indian virus a “variant of concern,” the UK is planning to use a lab-grown virus variant in challenge trials of current and new vaccines, and is also investing in new variant vaccine testing facilities. A new study will use Oxford Immunotec’s T cell test to monitor people’s immunological response to infection or vaccination.